Excited that our review article on the current and future use of patient induced pluripotent stem cells (iPSCs) to predict and stratify risk of drug-induced cardiotoxicity is online! (https://www.ahajournals.org/doi/10.1161/ATVBAHA.120.314695) Here, we discuss the types of drug-induced cardiotoxicity, the current iPSC modeling platforms, and five iPSC applications in identifying patients who are more susceptible for drug-induced cardiotoxicity. This is a fast growing field and we certainly look forward to more exciting studies in the future.
Thank Arteriosclerosis, Thrombosis and Vascular Biology for the opportunity!
Comentários